Skip to content

Latest News & Upcoming Events

Article: August 17, 2017 | Primary Care Optometry News

MacuLogix Board Develops Consensus Paper

MacuLogix has announced the launch of an optometric advisory board tasked with documenting the standard of care for treating AMD.

Read Article
Article: July 19, 2017 | Central Penn Business Journal

Biotech Firm MacuLogix Receives $500K in Funding

Harrisburg-based Life Sciences Greenhouse of Central Pennsylvania has invested additional funding.

Read Article
Article: July 12, 2017 | Review of Optometric Business

New Guide: Steps to Effectively Communicate an AMD Diagnosis

“12 Ways to Turn an AMD Diagnosis into News That’s Worth Celebrating,” co-authored by Laurie Sorrenson, OD, FAAO, is designed to offer useful advice for doctors treating AMD patients.

Read Article
Article: June 15, 2017 | Review of Optometry

Quarterbacking Retinal Disease

Paul Karpecki OD, FAAO explains that with the right technology and the right team, optometrists can be confident when taking the next step—early diagnosis.

Read Article
Article: June 5, 2017 | Primary Optometry News

Study Identifies Factors Affecting Dark Adaptation in AMD Patients

A slow dark adaptation is a recognized functional outcome of AMD.

Read Article
Article: March 15, 2017 | Review of Optometry

Through My Eyes: Diagnos-tech Advances

Paul Karpecki, OD explains how greater precision in measuring ocular and visual status helps us spot disease earlier.

Read Article
Article: February 1, 2017 |

New Vision Test in Wilmington Will Spare Many from ‘Devastating Diagnosis’

AdaptDx allows Edward Paul, OD diagnose AMD years before it presents as blindness.

Read Article
Article: January 2017 | Primary Care Optometry News

Dark Adaptation Test May Detect AMD Earlier than Traditional Technology

Clinicians are beginning to recognize that dark adaptation testing may indicate a diagnosis of age-related macular degeneration in patients who have no other clinical signs.

Read Article
Article: January 2017 | Primary Care Optometry News

Abnormal Dark Adaptation: An Early Biomarker for AMD

Michael DePaolis, OD, FAAO explains that abnormal dark adaptation may be a reliable early biomarker for AMD.

Read Article
Article: November 8, 2016 | WECT Wilmington Channel 6 (NBC affiliate) 

New Technology Used to Treat Macular Degeneration Years Before Symptoms Arise

A major breakthrough in eye research has been released to diagnose AMD using AdaptDx, years before any symptoms occur.

Read Article